Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, October 25, 2015

Take part in the Phase 3 clinical study for people with walking problems at least 6 months after an ischemic stroke

Join the MILESTONE(TM) Stroke Study per the NSA.

Your choice. Ask your doctor why they haven't told you about this study before you ask them about it?

The actual study here with the drug being tested:

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets for Treatment of Stable Walking Deficits in Post-Ischemic Stroke (MILESTONE℠)

The NSA news release:

Take part in the Phase 3 clinical study for people with walking problems at least 6 months after an ischemic stroke

Why is this study important?

Currently, there are no FDA approved medications available for improving the walking problems in these patients. Physical therapy and rehabilitation are the current mainstays of treatment to assist with walking problems following a stroke. Pharmaceutical companies use medical research studies such as the MILESTONE^SM Stroke Study to learn more about unapproved medications before they are made available to the public. By taking part in this study, you will be making a contribution to stroke therapy research.

What are the challenges related to this study?

The investigational medication has been approved as a treatment to improve walking problems associated with a different disease, however not in patients recovering from a stroke. This use is still investigational. The investigational medication is being tested in people who have had an ischemic stroke, because this condition has some nervous system changes that may be similar to what is seen in the disease for which this medication is approved. In an earlier study with about 80 participants who have had a stroke, there was some initial evidence of improvement in walking while taking the investigational medication twice a day for 2 weeks, when compared with a placebo.

TO PRE-QUALIFY FOR THIS STUDY, YOU MUST:

be 18 years of age or older
have had an ischemic stroke 6 months ago or longer
have walking problems as a result of the ischemic stroke, such as walking more slowly or needing to use a cane or walker.

YOU MUST NOT:

have a history of seizures, except simple febrile seizures
have moderate or severe renal impairment
have had Botox within the past 2 months
be pregnant, breastfeeding, or planning to become pregnant (if you are a woman able to have children).

All study-related visits, assessments, and study medication will be provided to participants at no cost. In addition, compensation for time and travel may be provided.